The OVMA supports Partners for Healthy Pets, a national coalition of veterinary associations and
animal health companies under the umbrella of the American Veterinary Medical Foundation.
Jaguar
Animal Health, Inc. (NASDAQ: JAGX) and Elanco US Inc., a subsidiary of Eli Lilly and
Company (NYSE: LLY), today announced an agreement (the «Agreement») to license, develop, and commercialize Canalevia ™, a Jaguar drug product candidate
under investigation for treatment of acute and chemotherapy - induced diarrhea («CID») in dogs.
March 8, 2010 - Paris, France — Pfizer
Animal Health today welcomed the signing of an agreement between Pfizer and Elanco, the animal health business unit of Eli Lilly and Company, under which Elanco will acquire European rights to a portfolio of certain Pfizer Animal Health and legacy Fort Dodge Animal Health pro
Animal Health today welcomed the signing of an agreement between Pfizer and Elanco, the animal health business unit of Eli Lilly and Company, under which Elanco will acquire European rights to a portfolio of certain Pfizer Animal Health and legacy Fort Dodge Animal Health pro
Health today welcomed the signing of an agreement between Pfizer and Elanco, the
animal health business unit of Eli Lilly and Company, under which Elanco will acquire European rights to a portfolio of certain Pfizer Animal Health and legacy Fort Dodge Animal Health pro
animal health business unit of Eli Lilly and Company, under which Elanco will acquire European rights to a portfolio of certain Pfizer Animal Health and legacy Fort Dodge Animal Health pro
health business unit of Eli Lilly and
Company,
under which Elanco will acquire European rights to a portfolio of certain Pfizer
Animal Health and legacy Fort Dodge Animal Health pro
Animal Health and legacy Fort Dodge Animal Health pro
Health and legacy Fort Dodge
Animal Health pro
Animal Health pro
Health products.